They found common transcriptional pathways that were upregulated in the tumor, stroma, and CD4 T cell populations of ERG negative patient tumors, including the PD-1 and IFNγ signaling pathway, suggesting that ERG tumor cells may give rise to a distinct immune cell niche in the TME. The gene discussed is ERG; the disease is neoplasm.